GenomOncology, a Cleveland company that has developed a technology platform to streamline the use of next-generation sequencing data in medical care and research, said it has named Dr. Joshua F. Coleman as vice president of medical affairs.

Coleman “will oversee clinical content development and curation of scientific evidence, enhancing the company’s proprietary knowledge-enabled platform,” GenomOncology said in a news release.

Before joining GenomOncology, Coleman was an assistant professor at the Ohio State University College of Medicine and practiced molecular genetic pathology in the James Cancer Hospital Molecular Laboratory.

Read the full story at Crain’s Cleveland Business.